Phase 3 ESSENCE Trial: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
Unknown authors
Topics & Concepts
SemaglutideSteatohepatitisNonalcoholic steatohepatitisMedicineSteatosisInternal medicinePhilosophyDiabetes mellitusEndocrinologyFatty liverType 2 diabetesDiseaseLiraglutideNonalcoholic fatty liver diseaseLiver Disease Diagnosis and TreatmentMetabolism, Diabetes, and CancerDiabetes Treatment and Management